Henrik Hager

6.6k total citations · 1 hit paper
119 papers, 4.6k citations indexed

About

Henrik Hager is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Henrik Hager has authored 119 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 30 papers in Pulmonary and Respiratory Medicine and 28 papers in Cancer Research. Recurrent topics in Henrik Hager's work include RNA modifications and cancer (15 papers), MicroRNA in disease regulation (14 papers) and Cancer-related molecular mechanisms research (13 papers). Henrik Hager is often cited by papers focused on RNA modifications and cancer (15 papers), MicroRNA in disease regulation (14 papers) and Cancer-related molecular mechanisms research (13 papers). Henrik Hager collaborates with scholars based in Denmark, United States and Hungary. Henrik Hager's co-authors include Lasse S. Kristensen, Jørgen Kjems, Theresa Jakobsen, Lise Lotte Hansen, Jørgen Gliemann, Poul Henning Jensen, Morten S. Nielsen, Ross Jakes, Peter Højrup and Tae‐Hwan Kwon and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Henrik Hager

114 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The emerging roles of circRNAs in cancer and oncology

2021 788 citations Lasse S. Kristensen, Theresa Jakobsen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Henrik Hager Denmark	35	2.7k	1.5k	857	780	551	119	4.6k
Annalisa Pession Italy	41	3.1k 1.2×	1.2k 0.8×	675 0.8×	912 1.2×	473 0.9×	144	5.8k
Thomas F. Westbrook United States	28	4.4k 1.7×	1.5k 1.0×	906 1.1×	1.4k 1.8×	409 0.7×	41	5.9k
Neil V. Morgan United Kingdom	42	3.0k 1.1×	1.0k 0.7×	1.2k 1.4×	505 0.6×	754 1.4×	109	5.7k
Ole Didrik Lærum Norway	42	2.0k 0.7×	941 0.6×	539 0.6×	1.3k 1.7×	643 1.2×	200	5.3k
Darrell J. Yamashiro United States	42	3.4k 1.3×	908 0.6×	563 0.7×	942 1.2×	334 0.6×	128	5.6k
Stanislawa Weremowicz United States	43	2.8k 1.1×	672 0.4×	803 0.9×	812 1.0×	448 0.8×	81	5.6k
Mutsuo Furihata Japan	36	1.9k 0.7×	861 0.6×	1.2k 1.4×	1.1k 1.4×	403 0.7×	184	4.4k
Toshimitsu Suzuki Japan	36	1.7k 0.6×	657 0.4×	659 0.8×	667 0.9×	218 0.4×	201	4.3k
August Vidal Spain	38	3.1k 1.2×	1.7k 1.1×	484 0.6×	856 1.1×	535 1.0×	110	5.2k
Yuchen Jiao China	36	1.9k 0.7×	1.1k 0.7×	713 0.8×	2.0k 2.5×	485 0.9×	89	5.8k

Countries citing papers authored by Henrik Hager

Since Specialization

Citations

This map shows the geographic impact of Henrik Hager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henrik Hager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henrik Hager more than expected).

Fields of papers citing papers by Henrik Hager

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henrik Hager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henrik Hager. The network helps show where Henrik Hager may publish in the future.

Co-authorship network of co-authors of Henrik Hager

This figure shows the co-authorship network connecting the top 25 collaborators of Henrik Hager. A scholar is included among the top collaborators of Henrik Hager based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henrik Hager. Henrik Hager is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

García‐Rodríguez, Juan L., Sanne Kjær‐Frifeldt, Jan Lindebjerg, et al.. (2025). The prognostic potential of RNA in stage II colon cancer: Insights from a screened multicenter population‐based cohort study. International Journal of Cancer. 157(8). 1746–1755.

García‐Rodríguez, Juan L., Marina N. Semenova, Hannah L. Williams, et al.. (2025). Cancer-associated fibroblasts shape the formation of budding cancer cells at the invasive front of human colorectal cancer. Communications Biology. 8(1). 1345–1345.

Olesen, Morten T. Jarlstad, Juan L. García‐Rodríguez, Robert A. Fenton, et al.. (2025). ciRS-7 expression is epigenetically regulated in cancer cells across human adenocarcinomas. PLoS Genetics. 21(6). e1011726–e1011726. 1 indexed citations

García‐Rodríguez, Juan L., Theresa Jakobsen, Ulvi Ahmadov, et al.. (2024). The Transcriptional Landscape of Coding and Noncoding RNAs in Recurrent and Nonrecurrent Colon Cancer. American Journal Of Pathology. 194(8). 1424–1442. 3 indexed citations

Joseph, Justin V., Huiqiang Cai, Fabienne Vernejoul, et al.. (2023). STING activation counters glioblastoma by vascular alteration and immune surveillance. Cancer Letters. 579. 216480–216480. 14 indexed citations

Ladekarl, Morten, et al.. (2023). Gene Expressions and High Lymphocyte Count May Predict Durable Clinical Benefits in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors. Cancers. 15(18). 4480–4480. 2 indexed citations

García‐Rodríguez, Juan L., Ulvi Ahmadov, Morten T. Jarlstad Olesen, et al.. (2023). Spatial Profiling of Circular RNAs in Cancer Reveals High Expression in Muscle and Stromal Cells. Cancer Research. 83(20). 3340–3353. 19 indexed citations

Nielsen, Thomas, et al.. (2022). Spatial analysis of photoplethysmography in cutaneous squamous cell carcinoma. Scientific Reports. 12(1). 7318–7318. 1 indexed citations

Andersen, Rikke Fredslund, Torben Frøstrup Hansen, Line Nederby, et al.. (2021). Validating Methylated HOXA9 in Bronchial Lavage as a Diagnostic Tool in Patients Suspected of Lung Cancer. Cancers. 13(16). 4223–4223. 4 indexed citations

10.

Tsoi, Lam C., Ranjitha Uppala, Henrik Hager, et al.. (2020). Characterization of circular RNA transcriptomes in psoriasis and atopic dermatitis reveals disease‐specific expression profiles. Experimental Dermatology. 30(8). 1187–1196. 39 indexed citations

11.

Andersen, Rikke Fredslund, et al.. (2020). Comparison of Mutated KRAS and Methylated HOXA9 Tumor-Specific DNA in Advanced Lung Adenocarcinoma. Cancers. 12(12). 3728–3728. 13 indexed citations

12.

Cho, Jong Ho, Yoon‐La Choi, Yu Feng, et al.. (2017). Programmed Death Ligand 1 Expression in Paired Non–Small Cell Lung Cancer Tumor Samples. Clinical Lung Cancer. 18(6). e473–e479. 32 indexed citations

13.

Sørensen, Brita Singers, Jan Alsner, Jens Overgaard, et al.. (2013). Identification of accurate reference genes for RT-qPCR analysis of formalin-fixed paraffin-embedded tissue from primary Non-Small Cell Lung Cancers and brain and lymph node metastases. Lung Cancer. 81(2). 180–186. 32 indexed citations

14.

Lade‐Keller, Johanne, Per Guldberg, Rikke Riber‐Hansen, et al.. (2012). Evaluation of BRAF Mutation Testing Methodologies in Formalin-Fixed, Paraffin-Embedded Cutaneous Melanomas. Journal of Molecular Diagnostics. 15(1). 70–80. 57 indexed citations

15.

Andresen, Jens, Thomas Ledet, Henrik Hager, Kaj Josephsen, & Niels Ehlers. (2000). The Influence of Corneal Stromal Matrix Proteins on the Migration of Human Corneal Fibroblasts. Experimental Eye Research. 71(1). 33–43. 43 indexed citations

16.

Aboagye‐Mathiesen, George, et al.. (1997). Epstein–Barr Virus Permissively Infects Human Syncytiotrophoblastsin Vitroand Induces Replication of Human T Cell Leukemia-Lymphoma Virus Type I in Dually Infected Cells. Virology. 229(2). 400–414. 15 indexed citations

17.

Zdravković, Milan, Hans Jørgen Knudsen, Henrik Hager, et al.. (1997). High interferon alpha levels in placenta, maternal, and cord blood suggest a protective effect against intrauterine herpes simplex virus infection. Journal of Medical Virology. 51(3). 210–213. 29 indexed citations

18.

Jensen, Poul Henning, Thomas G. Jensen, Walter E. Laug, et al.. (1996). The Exon 3 Encoded Sequence of the Intracellular Serine Proteinase Inhibitor Plasminogen Activator Inhibitor 2 Is a Protein Binding Domain. Journal of Biological Chemistry. 271(43). 26892–26899. 27 indexed citations

19.

Zachar, Vladimir, et al.. (1996). Transfer of human T cell lymphotropic virus type I to human term trophoblast cells in vitro. Journal of General Virology. 77(2). 369–374. 4 indexed citations

20.

Zdravković, Milan, George Aboagye‐Mathiesen, Vladimir Zachar, et al.. (1994). Immunosuppressive effects of human placental trophoblast interferon-β on lymphocytes in vitro. Placenta. 15(6). 591–600. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact